首页> 外文期刊>急性病杂志(英文版) >Prospected epigenetic moderators from natural sources and drug of class NSAIDS as effective treatment options to Prostate cancer
【24h】

Prospected epigenetic moderators from natural sources and drug of class NSAIDS as effective treatment options to Prostate cancer

机译:天然来源和NSAIDS类药物的预期表观遗传调节剂可作为治疗前列腺癌的有效方法

获取原文
获取原文并翻译 | 示例
       

摘要

Prostate cancer (PC) is one of the most common and leading cancer amongst the males all around the world. Depending upon it long latency and cost involved in its management and treatment, there is extensive need for more personalized and economical therapeutic approach for its effective therapy. The current review here discusses agents from natural dietary sources and drug class Non-Steroidal Antinflammatory (NSAIDS) that bears chemopreventive potential to regulate PC progression & tumour development and therefore could be devised into effective future treatment strategy against PC along with its metastatic castration-resistant form. Based on the literature search the therapeutic scope of selected agents are delineated, sighting their previous activity and prospects as epigenetic moderators in specific to particular PC causing biomarkers like over expression of AKR1C3, lost intracellular glutathione/glutathione-s-tranferases(GSH/GST) expression, DNA hypermethylation, aberrant cell proliferation and other related factors that are thought to potentiate and aggravate the onset of PC like smoking and use of other narcotics products.
机译:前列腺癌(PC)是世界各地的男性中最常见和最常见的癌症之一。根据其管理和治疗中涉及的长期延迟和成本,有广泛的需求对其有效治疗的更加个性化和经济的治疗方法。目前的评论讨论了来自天然膳食来源和药物类非甾体抗炎(NSAIDs)的药物,用于调节PC进展和肿瘤发育的化学预防潜力,因此可以设计成有效的未来对抗PC的治疗策略以及其转移性阉割抵抗力形式。基于文献搜索,所选试剂的治疗范围被描绘,观察其先前的活性和前景,作为表观遗传调节剂在特定的特定PC,导致生物标志物如AKR1C3的表达,丢失的细胞内谷胱甘肽/谷胱甘肽-S- ranferase(GSH / GST)表达,DNA高甲基化,异常细胞增殖和其他相关因素被认为具有增强和加剧PC的发作,如吸烟和使用其他麻醉产品。

著录项

  • 来源
    《急性病杂志(英文版)》 |2017年第4期|145-153|共9页
  • 作者单位

    Volhart Health Care Pvt. Ltd., Department of Research and Development, Sitapur Road Yojna, Lucknow,UP, India;

    Faculty of Life and Health Sciences, School of Biomedical Sciences, University of Ulster, Coleraine, BT521SA, United Kingdom;

    Babu Banarasi Das Northern India Institute of Technology, Department of Pharmacy, Faizabad Road, Lucknow,UP, India;

    Sam Higginbottom University of Agriculture, Technology and Sciences, Department of Pharmaceutical Sciences, Allahabad, Naini, UP, India;

    Department of Pharmacy, Himachal Institute of Pharmacy, Paonta Sahib-173025, H.P India;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:43:44
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号